Biomedical subjects
M DeMaio
Publications and source records attributed to M DeMaio.
Eversion ankle sprains.
Explore the source record for details and available documents.
Rehabilitation after meniscus repair.
Explore the source record for details and available documents.
Chronic lateral ankle instability--inversion sprains: Part I.
Explore the source record for details and available documents.
Chronic lateral ankle instability--inversion sprains: Part II.
Explore the source record for details and available documents.
Principles for aggressive rehabilitation after reconstruction of the anterior cruciate ligament.
Explore the source record for details and available documents.
Minimal protection program: advanced weight bearing and range of motion after ACL reconstruction--weeks 1 to 5.
Explore the source record for details and available documents.
Advanced muscle training after ACL reconstruction: weeks 6 to 52.
Explore the source record for details and available documents.
Rehabilitation after ACL reconstruction: function testing.
Explore the source record for details and available documents.
Rehabilitative techniques in the treatment of medial and lateral epicondylitis.
Explore the source record for details and available documents.
Evaluation-based protocols: a new approach to rehabilitation.
Explore the source record for details and available documents.
Role of the primary care nurse in employee health service.
Explore the source record for details and available documents.
The effects of levonantradol hydrochloride on tumor growth and therapy.
The effects of levonantradol on tumor growth, both directly and in combination with the cytotoxic agent cyclophosphamide, were determined. Levonantradol hydrochloride administered alone had no effect on the progression of either murine sarcoma 180J or leukemia L-1210. Likewise, the increased survival obtained in both tumor systems with cyclophosphamide was not altered by concurrent administration of levonantradol hydrochloride. Levonantradol did not affect the incidence or extent of artificial melanotic lung metastases, nor did it modify lymphoreticular cell stimulation. These data support the use of levonantradol in conjunction with chemotherapy in cancer patients.